Skip to main content
Top
Published in: European Archives of Psychiatry and Clinical Neuroscience 5/2017

Open Access 01-08-2017 | Original Paper

Inflammatory processes and schizophrenia: two independent lines of evidence from a study of twins discordant and concordant for schizophrenic disorders

Authors: Silke Braun, René Bridler, Norbert Müller, Markus J. Schwarz, Erich Seifritz, Matthias Weisbrod, Alexandra Zgraggen, Hans H. Stassen

Published in: European Archives of Psychiatry and Clinical Neuroscience | Issue 5/2017

Login to get access

Abstract

The concept of twin concordance involves quantifying the resemblance between co-twins in an “objective” and reproducible way. Yet, quantifying resemblance in the case of complex psychiatric traits like schizophrenic disorders leads to methodological problems, as the yes–no dichotomy of diagnostic schemata does not allow one to assess between-subject differences in psychopathology patterns sufficiently accurately. Therefore, we relied on a multidimensional, quantitative concordance measure that provided a high resolution and differentiation when assessing the resemblance of psychopathology patterns. This concordance measure was central to our investigations into the potential link between schizophrenic disorders and aberrancies of the inflammatory response system. Specifically, we aimed to determine the extent to which (1) the observed variation of between-subject psychopathology concordance among 100 schizophrenic patients and (2) the observed variation of within-pair psychopathology concordance among 71 twin pairs can be explained by immunoglobulin M (IgM) levels. To accomplish this goal, we had to “gauge” in a first step the concordance measure’s performance by (1) comparing the psychopathology patterns of 269 index cases suffering from functional psychoses with the respective patterns of the 350 “affecteds” among their first-degree relatives; (2) systematically comparing the psychopathology patterns of 100 unrelated patients with a diagnosis of schizophrenic disorders with each other; and (3) detailing the within-pair concordance of elementary traits among 2734 healthy twin pairs. As to the role of active immune processes in the context of schizophrenic disorders, we found that there exists a 20–30% subgroup of patients for whom aberrancies of the inflammatory response system, as quantified through IgM levels, appeared to be linked to the pathogenesis of schizophrenic disorders (r = 0.7515/0.8184, p < 0.0001). The variation of within-pair psychopathology concordance among twins with schizophrenic disorders was found to be “explainable” in part by chronically elevated IgM levels (24.5% of observed phenotypic variance; p = 0.0434), thus suggesting that monozygotic twins concordant for schizophrenic disorders may possess a less “robust” variant of the inflammatory response system which can more easily be triggered by exogenous factors than the more “robust” variants of discordant pairs. Though the underlying biological mechanisms remain to be detected, our data have cleared the way for an early identification of patients with schizophrenic disorders for whom the inflammatory response system may be a target for therapeutic intervention. Moreover, our results will likely lead to new treatment strategies that involve elements of personalized medicine.
Footnotes
1
IgM autoantibodies are proteins produced by the immune system in response to a perceived threat—which also may be the result of an aberrant immune response of the organism against its own cells and tissues (autoimmune inflammatory processes).
 
3
IgM levels were determined by the Viollier Laboratories, Basel.
 
4
Data courtesy Müller N. and Schwarz M.
 
5
Data courtesy David T. Lykken.
 
6
“Concordance” and “discordance” are inversely related to each other.
 
7
This is different from the qualitative diagnosis-oriented approach where co-twins who both meet the diagnostic threshold are deemed to be perfectly concordant (100%) irrespective of differences in their psychopathology pattern. Analogously, if one co-twin does not meet the diagnostic criteria and the second co-twin does, the pair is treated as perfectly discordant.
 
Literature
1.
go back to reference Bleuler E (1911) Dementia praecox or the group of schizophrenias. International Universities Press, New York Bleuler E (1911) Dementia praecox or the group of schizophrenias. International Universities Press, New York
2.
go back to reference Gottesman II (1991) Schizophrenia Genesis: the origins of madness. New York: W. H. Freeman, Series of Books in Psychology, 296 pp Gottesman II (1991) Schizophrenia Genesis: the origins of madness. New York: W. H. Freeman, Series of Books in Psychology, 296 pp
3.
go back to reference Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E, Mortensen PB (2006) Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry 163(3):521–528CrossRefPubMed Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E, Mortensen PB (2006) Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry 163(3):521–528CrossRefPubMed
4.
go back to reference Shelton RC, Miller AH (2010) Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol 91:275–299CrossRefPubMedPubMedCentral Shelton RC, Miller AH (2010) Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol 91:275–299CrossRefPubMedPubMedCentral
5.
go back to reference Müller N, Myint AM, Krause D, Weidinger E, Schwarz MJ (2013) Anti-inflammatory treatment in schizophrenia. Progess Neuro Psychopharmacol Biol Psychiatry 42:146–153CrossRef Müller N, Myint AM, Krause D, Weidinger E, Schwarz MJ (2013) Anti-inflammatory treatment in schizophrenia. Progess Neuro Psychopharmacol Biol Psychiatry 42:146–153CrossRef
6.
go back to reference Tourjman V, Kouassi É, Koué MÈ, Rocchetti M, Fortin-Fournier S, Fusar-Poli P, Potvin S (2013) Antipsychotics’ effects on blood levels of cytokines in schizophrenia: a meta-analysis. Schizophr Res 151(1–3):43–47CrossRefPubMed Tourjman V, Kouassi É, Koué MÈ, Rocchetti M, Fortin-Fournier S, Fusar-Poli P, Potvin S (2013) Antipsychotics’ effects on blood levels of cytokines in schizophrenia: a meta-analysis. Schizophr Res 151(1–3):43–47CrossRefPubMed
7.
go back to reference Abelaira HM, Réus GZ, Petronilho F, Barichello T, Quevedo J (2014) Neuroimmunomodulation in depression: a review of inflammatory cytokines involved in this process. Neurochem Res 39(9):1634–1639CrossRefPubMed Abelaira HM, Réus GZ, Petronilho F, Barichello T, Quevedo J (2014) Neuroimmunomodulation in depression: a review of inflammatory cytokines involved in this process. Neurochem Res 39(9):1634–1639CrossRefPubMed
8.
go back to reference Girgis RR, Kumar SS, Brown AS (2014) The cytokine model of schizophrenia: emerging therapeutic strategies. Biol Psychiatry 75(4):292–299CrossRefPubMed Girgis RR, Kumar SS, Brown AS (2014) The cytokine model of schizophrenia: emerging therapeutic strategies. Biol Psychiatry 75(4):292–299CrossRefPubMed
10.
go back to reference Sommer IE, van Westrhenen R, Begemann MJ, de Witte LD, Leucht S, Kahn RS (2014) Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update. Schizophr Bull 40(1):181–191CrossRefPubMed Sommer IE, van Westrhenen R, Begemann MJ, de Witte LD, Leucht S, Kahn RS (2014) Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update. Schizophr Bull 40(1):181–191CrossRefPubMed
11.
go back to reference Uher R, Tansey KE, Dew T, Maier W, Mors O, Hauser J, Dernovsek MZ, Henigsberg N, Souery D, Farmer A, McGuffin P (2014) An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline. Am J Psychiatry 171(12):1278–1286CrossRefPubMed Uher R, Tansey KE, Dew T, Maier W, Mors O, Hauser J, Dernovsek MZ, Henigsberg N, Souery D, Farmer A, McGuffin P (2014) An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline. Am J Psychiatry 171(12):1278–1286CrossRefPubMed
12.
go back to reference Berckel van BN, Bossong MG, Boellaard R, Kloet R, Schuitemaker A, Caspers E, Luurtsema G, Windhorst AD, Cahn W, Lammertsma AA, Kahn RS (2008) Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol Psychiatry 64(9):820–822CrossRefPubMed Berckel van BN, Bossong MG, Boellaard R, Kloet R, Schuitemaker A, Caspers E, Luurtsema G, Windhorst AD, Cahn W, Lammertsma AA, Kahn RS (2008) Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol Psychiatry 64(9):820–822CrossRefPubMed
13.
go back to reference Laskaris LE, Di Biase MA, Everall I, Chana G, Christopoulos A, Skafidas E, Cropley VL, Pantelis C (2016) Microglial activation and progressive brain changes in schizophrenia. Br J Pharmacol 173(4):666–680CrossRefPubMedPubMedCentral Laskaris LE, Di Biase MA, Everall I, Chana G, Christopoulos A, Skafidas E, Cropley VL, Pantelis C (2016) Microglial activation and progressive brain changes in schizophrenia. Br J Pharmacol 173(4):666–680CrossRefPubMedPubMedCentral
14.
go back to reference Trépanier MO, Hopperton KE, Mizrahi R, Mechawar N, Bazinet RP (2016) Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review. Mol Psychiatry 21(8):1009–1026CrossRefPubMedPubMedCentral Trépanier MO, Hopperton KE, Mizrahi R, Mechawar N, Bazinet RP (2016) Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review. Mol Psychiatry 21(8):1009–1026CrossRefPubMedPubMedCentral
15.
go back to reference Altamura AC, Bassetti R, Cattaneo E, Vismara S (2005) Some biological correlates of drug resistance in schizophrenia: a multidimensional approach. World J Biol Psychiatry 6(Suppl. 2):23–30CrossRefPubMed Altamura AC, Bassetti R, Cattaneo E, Vismara S (2005) Some biological correlates of drug resistance in schizophrenia: a multidimensional approach. World J Biol Psychiatry 6(Suppl. 2):23–30CrossRefPubMed
16.
go back to reference Kaestner F, Hettich M, Peters M, Sibrowski W, Hetzel G, Ponath G, Arolt V, Cassens U, Rothermundt M (2005) Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J Affect Disord 87(2–3):305–311CrossRefPubMed Kaestner F, Hettich M, Peters M, Sibrowski W, Hetzel G, Ponath G, Arolt V, Cassens U, Rothermundt M (2005) Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J Affect Disord 87(2–3):305–311CrossRefPubMed
17.
go back to reference Müller N, Schwarz MJ (2006) Neuroimmune-endocrine crosstalk in schizophrenia and mood disorders. Expert Rev Neurother 6(7):1017–1038CrossRefPubMed Müller N, Schwarz MJ (2006) Neuroimmune-endocrine crosstalk in schizophrenia and mood disorders. Expert Rev Neurother 6(7):1017–1038CrossRefPubMed
18.
go back to reference Müller N, Schwarz MJ (2006) Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. Neurotox Res 10(2):131–148CrossRefPubMed Müller N, Schwarz MJ (2006) Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. Neurotox Res 10(2):131–148CrossRefPubMed
19.
go back to reference Müller N, Schwarz MJ (2007) The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry 12(11):988–1000CrossRefPubMed Müller N, Schwarz MJ (2007) The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry 12(11):988–1000CrossRefPubMed
20.
go back to reference Kim YK, Na KS, Shin KH, Jung HY, Choi SH, Kim JB (2007) Cytokine imbalance in the pathophysiology of major depressive disorder. Progress Neuro Psychopharmacol Biol Psychiatry 31(5):1044–1053CrossRef Kim YK, Na KS, Shin KH, Jung HY, Choi SH, Kim JB (2007) Cytokine imbalance in the pathophysiology of major depressive disorder. Progress Neuro Psychopharmacol Biol Psychiatry 31(5):1044–1053CrossRef
21.
go back to reference Rosenblat JD, Cha DS, Mansur RB, McIntyre RS (2014) Inflamed moods: a review of the interactions between inflammation and mood disorders. Progess Neuro Psychopharmacol Biol Psychiatry 53:23–34CrossRef Rosenblat JD, Cha DS, Mansur RB, McIntyre RS (2014) Inflamed moods: a review of the interactions between inflammation and mood disorders. Progess Neuro Psychopharmacol Biol Psychiatry 53:23–34CrossRef
23.
go back to reference Stassen HH, Szegedi A, Scharfetter C (2007) Modeling activation of inflammatory response system. A molecular-genetic neural network analysis. BMC Proc 1(Suppl. 1):S61CrossRefPubMedPubMedCentral Stassen HH, Szegedi A, Scharfetter C (2007) Modeling activation of inflammatory response system. A molecular-genetic neural network analysis. BMC Proc 1(Suppl. 1):S61CrossRefPubMedPubMedCentral
24.
go back to reference Nielen MM, van Schaardenburg D, Reesink HW, Twisk JW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, Habibuw MR, Dijkmans BA (2006) Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis. Ann Rheum Dis 65(4):535–537CrossRefPubMed Nielen MM, van Schaardenburg D, Reesink HW, Twisk JW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, Habibuw MR, Dijkmans BA (2006) Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis. Ann Rheum Dis 65(4):535–537CrossRefPubMed
25.
go back to reference Angst J, Scharfetter C, Stassen HH, Winokur G (1988) SADS Syndrome Checklist SSCL-16 and SSCL-16 Supplement. Psychiatric University Hospital Zurich Angst J, Scharfetter C, Stassen HH, Winokur G (1988) SADS Syndrome Checklist SSCL-16 and SSCL-16 Supplement. Psychiatric University Hospital Zurich
26.
go back to reference Endicott J, Spitzer RL (1978) A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35(7):873–943CrossRef Endicott J, Spitzer RL (1978) A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35(7):873–943CrossRef
27.
go back to reference Jones AL, Mowry BJ, Pender MP, Greer JM (2005) Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis? Immunol Cell Biol 83(1):9–17CrossRefPubMed Jones AL, Mowry BJ, Pender MP, Greer JM (2005) Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis? Immunol Cell Biol 83(1):9–17CrossRefPubMed
28.
go back to reference Strous RD, Shoenfeld Y (2006) Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. J Autoimmun 27(2):71–80CrossRefPubMed Strous RD, Shoenfeld Y (2006) Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. J Autoimmun 27(2):71–80CrossRefPubMed
29.
go back to reference Fan X, Goff DC, Henderson DC (2007) Inflammation and schizophrenia. Expert Rev Neurother 7(7):789–796CrossRefPubMed Fan X, Goff DC, Henderson DC (2007) Inflammation and schizophrenia. Expert Rev Neurother 7(7):789–796CrossRefPubMed
30.
go back to reference Saetre P, Emilsson L, Axelsson E, Kreuger J, Lindholm E, Jazin E (2007) Inflammation-related genes up-regulated in schizophrenia brains. BMC Psychiatry 7(1):46CrossRefPubMedPubMedCentral Saetre P, Emilsson L, Axelsson E, Kreuger J, Lindholm E, Jazin E (2007) Inflammation-related genes up-regulated in schizophrenia brains. BMC Psychiatry 7(1):46CrossRefPubMedPubMedCentral
31.
go back to reference Müller N, Krause D, Weidinger E, Schwarz M (2014) Immunological treatment options for schizophrenia. Fortschr Neurol Psychiatr 82(4):210–219CrossRefPubMed Müller N, Krause D, Weidinger E, Schwarz M (2014) Immunological treatment options for schizophrenia. Fortschr Neurol Psychiatr 82(4):210–219CrossRefPubMed
32.
go back to reference Stassen HH, Coppola R, Torrey EF, Gottesman II, Kuny S, Rickler KC, Hell D (1999) EEG differences in monozygotic twins discordant and concordant for schizophrenia. Psychophysiology 36(1):109–117CrossRefPubMed Stassen HH, Coppola R, Torrey EF, Gottesman II, Kuny S, Rickler KC, Hell D (1999) EEG differences in monozygotic twins discordant and concordant for schizophrenia. Psychophysiology 36(1):109–117CrossRefPubMed
33.
go back to reference Weisbrod M, Hill H, Sauer H, Niethammer R, Guggenbühl S, Stassen HH (2004) Nongenetic pathologic developments of brain-wave patterns in monozygotic twins discordant and concordant for schizophrenia. Am J Med Genet 125:1–9CrossRef Weisbrod M, Hill H, Sauer H, Niethammer R, Guggenbühl S, Stassen HH (2004) Nongenetic pathologic developments of brain-wave patterns in monozygotic twins discordant and concordant for schizophrenia. Am J Med Genet 125:1–9CrossRef
Metadata
Title
Inflammatory processes and schizophrenia: two independent lines of evidence from a study of twins discordant and concordant for schizophrenic disorders
Authors
Silke Braun
René Bridler
Norbert Müller
Markus J. Schwarz
Erich Seifritz
Matthias Weisbrod
Alexandra Zgraggen
Hans H. Stassen
Publication date
01-08-2017
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Psychiatry and Clinical Neuroscience / Issue 5/2017
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-017-0792-z

Other articles of this Issue 5/2017

European Archives of Psychiatry and Clinical Neuroscience 5/2017 Go to the issue